No Data
Is Aldeyra Therapeutics (ALDX) Among Billionaire Joseph Edelman's Long-Term Stock Picks?
Oppenheimer Maintains Aldeyra Therapeutics(ALDX.US) With Buy Rating, Raises Target Price to $12
Analysts' Top Healthcare Picks: Aldeyra Therapeutics (ALDX), Keros Therapeutics (KROS)
Is the Options Market Predicting a Spike in Aldeyra Therapeutics (ALDX) Stock?
Positive Outlook for Aldeyra Therapeutics: Buy Rating Backed by Promising Reproxalap Prospects and Strategic Partnership With AbbVie
Aldeyra Therapeutics to Participate in the Citi 2024 Global Healthcare Conference